Meridian Clinical Research
Rejected
Stock
Company Overview
Meridian Clinical Research is a Connecticut-registered Stock that has been on file for 5 years. Its current status is Rejected. It is identified by file number 001t000000hmzhBAAQ. Its principal office is at 3319 N 107th Street, Omaha, NE, 68134.
Filing Information
Status
Rejected
Entity Type
Stock
Industry Code
Research and Development in Biotechnology (except Nanobiotechnology) (541714)
State Entity ID
001t000000hmzhBAAQ
Formation Date
07/09/2021
Formation State
NEBRASKA
Addresses
Principal Address
3319 N 107th Street, Omaha, NE, 68134
Other Businesses Registered in Connecticut
Record last updated on June 5, 2026 at 9:44 PM EST
Government records change frequently. The latest data can be pulled with a live lookup.